β-Amyloid 1-16

β-Amyloid (1-16) is a β-Amyloid protein fragment involved in metal binding. Beta-amyloid is a peptide that forms amyloid plaques in the brains of Alzheimer's disease (AD) patients.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
β-Amyloid 1-16(CAS 131580-10-4)

CAT No: R1771

CAS No:131580-10-4

Synonyms/Alias:131580-10-4;Amyloid beta-Protein (1-16);beta-Amyloid (1-16);Amyloid beta-Protein (1-16) trifluoroacetate salt;DA-50447;

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C84H119N27O28
M.W/Mr.
1955
Sequence
One Letter Code:DAEFRHDSGYEVHHQK
Three Letter Code:H-DL-Asp-DL-Ala-DL-Glu-DL-Phe-DL-Arg-DL-His-DL-Asp-DL-Ser-Gly-DL-Tyr-DL-Glu-DL-Val-DL-His-DL-His-DL-Gln-DL-Lys-OH

β-Amyloid 1-16 is a synthetic peptide fragment corresponding to the N-terminal residues 1 through 16 of the amyloid beta (Aβ) protein, a key molecular species implicated in neurodegenerative research. As a well-characterized segment of the larger amyloid beta peptide, it offers unique advantages for dissecting the structural and functional properties of amyloidogenic sequences. Its defined length and sequence specificity make it highly relevant for studies investigating the early events of amyloid aggregation, protein-protein interactions, and the molecular mechanisms underlying neurobiological processes. Researchers utilize this peptide as a model system to elucidate the role of N-terminal regions in Aβ biology, providing foundational insights into protein misfolding, aggregation pathways, and related pathologies.

Aggregation studies: β-Amyloid 1-16 serves as a valuable substrate for examining the initial stages of amyloid formation, particularly the nucleation and oligomerization processes that precede fibril assembly. Its truncated sequence allows researchers to isolate the contributions of the N-terminal domain to aggregation kinetics and morphology, enabling detailed investigations into the molecular determinants that govern amyloidogenicity. By comparing the behavior of this fragment with longer Aβ peptides, scientists can delineate sequence-dependent factors that influence aggregation propensity and structural transitions.

Protein interaction analysis: The peptide is frequently employed in binding assays to probe interactions with metal ions, antibodies, or small-molecule modulators. Its N-terminal residues are known to participate in metal coordination and epitope recognition, making it an ideal tool for characterizing binding affinities, mapping interaction sites, and screening for compounds that modulate Aβ-related pathways. Such studies are critical for understanding the molecular specificity of ligand recognition and for advancing the rational design of aggregation inhibitors or diagnostic reagents.

Structural biology research: β-Amyloid 1-16 is instrumental in high-resolution structural studies, including nuclear magnetic resonance (NMR) spectroscopy and X-ray crystallography, aimed at elucidating the conformational properties of amyloidogenic segments. Its manageable size and solubility facilitate detailed analysis of secondary structure, backbone dynamics, and solvent interactions. Insights gained from these structural investigations inform broader models of amyloid assembly and provide reference data for computational simulations of peptide folding and misfolding.

Antibody development: The defined sequence of this peptide fragment is widely utilized as an immunogen or screening target in the generation and characterization of Aβ-specific antibodies. Researchers employ it in enzyme-linked immunosorbent assays (ELISA), western blotting, and immunohistochemistry to assess antibody specificity, affinity, and cross-reactivity. This application is essential for developing reliable research tools, validating antibody performance, and supporting the discovery of novel detection reagents for amyloid-related studies.

Analytical method calibration: β-Amyloid 1-16 is also used as a standard or reference material in mass spectrometry, chromatography, and other quantitative analytical techniques. Its well-defined physicochemical properties allow accurate calibration of instrumentation, validation of peptide quantification protocols, and benchmarking of analytical workflows. This role is particularly important for ensuring reproducibility, sensitivity, and accuracy in the detection and measurement of amyloidogenic peptides in complex biological samples.

InChI
InChI=1S/C84H119N27O28/c1-41(2)68(82(137)109-59(30-47-35-92-40-97-47)80(135)107-57(28-45-33-90-38-95-45)78(133)102-51(18-21-62(87)114)73(128)104-54(83(138)139)12-7-8-24-85)111-75(130)53(20-23-65(118)119)103-76(131)55(27-44-14-16-48(113)17-15-44)99-63(115)36-94-71(126)61(37-112)110-81(136)60(32-67(122)123)108-79(134)58(29-46-34-91-39-96-46)106-72(127)50(13-9-25-93-84(88)89)101-77(132)56(26-43-10-5-4-6-11-43)105-74(129)52(19-22-64(116)117)100-69(124)42(3)98-70(125)49(86)31-66(120)121/h4-6,10-11,14-17,33-35,38-42,49-61,68,112-113H,7-9,12-13,18-32,36-37,85-86H2,1-3H3,(H2,87,114)(H,90,95)(H,91,96)(H,92,97)(H,94,126)(H,98,125)(H,99,115)(H,100,124)(H,101,132)(H,102,133)(H,103,131)(H,104,128)(H,105,129)(H,106,127)(H,107,135)(H,108,134)(H,109,137)(H,110,136)(H,111,130)(H,116,117)(H,118,119)(H,120,121)(H,122,123)(H,138,139)(H4,88,89,93)
InChI Key
PKSRFXGDLPWBBS-UHFFFAOYSA-N

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Epitope Mapping ServicesCustom Conjugation ServicePeptide Analysis ServicesPeptide Nucleic Acids SynthesiscGMP Peptide ServicePeptide CDMOPeptide Modification ServicesPeptide Synthesis Services
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers